BioNTech Stock Forward View - Price Action Indicator

22UA Stock  EUR 93.45  3.25  3.60%   
BioNTech Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of BioNTech's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 9th of February 2026 the rsi of BioNTech's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of BioNTech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of BioNTech and does not consider all of the tangible or intangible factors available from BioNTech's fundamental data. We analyze noise-free headlines and recent hype associated with BioNTech SE, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting BioNTech's stock price prediction:
Quarterly Earnings Growth
(0.43)
Wall Street Target Price
334.89
Quarterly Revenue Growth
0.22
Using BioNTech hype-based prediction, you can estimate the value of BioNTech SE from the perspective of BioNTech response to recently generated media hype and the effects of current headlines on its competitors.

BioNTech after-hype prediction price

    
  EUR 90.35  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of BioNTech to cross-verify your projections.

BioNTech Additional Predictive Modules

Most predictive techniques to examine BioNTech price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioNTech using various technical indicators. When you analyze BioNTech charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
BioNTech SE has current Price Action Indicator of 3.58. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check BioNTech VolatilityBacktest BioNTechInformation Ratio  

BioNTech Trading Date Momentum

On February 09 2026 BioNTech SE was traded for  93.45  at the closing time. The maximum traded price for the trading interval was 93.45  and the lowest daily price was  89.55 . The daily volume was recorded at 1.3 K. The volume of trading on 9th of February 2026 did not affect price variability. The overall trading delta to the closing price today is 2.84% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare BioNTech to competition

Other Forecasting Options for BioNTech

For every potential investor in BioNTech, whether a beginner or expert, BioNTech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BioNTech Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BioNTech. Basic forecasting techniques help filter out the noise by identifying BioNTech's price trends.

BioNTech Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioNTech stock to make a market-neutral strategy. Peer analysis of BioNTech could also be used in its relative valuation, which is a method of valuing BioNTech by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

BioNTech Market Strength Events

Market strength indicators help investors to evaluate how BioNTech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioNTech shares will generate the highest return on investment. By undertsting and applying BioNTech stock market strength indicators, traders can identify BioNTech SE entry and exit signals to maximize returns.

BioNTech Risk Indicators

The analysis of BioNTech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioNTech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biontech stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for BioNTech

The number of cover stories for BioNTech depends on current market conditions and BioNTech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioNTech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioNTech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:
Check out Historical Fundamental Analysis of BioNTech to cross-verify your projections.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Understanding that BioNTech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether BioNTech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.